Clinical Trial Update: Pegaspargase Combined With Gemcitabine, Etoposide, Liposomal Mitoxantrone Hydrochloride and Dexamethasone (P-GEMD) in the Treatment of Untreated Early Non-upper Respiratory Tract or Advanced Extranodal NK/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Pegaspargase with gemcitabine, etoposide, liposomal mitoxantrone, and dexamethasone (P-GEMD) for untreated early non-upper respiratory …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Etoposide (Etoposide)
• Gemcitabine (Gemcitabine)
• Liposome-encapsulated mitoxantrone hydrochloride (liposomal mitoxantrone hydrochloride)
• Pegaspargase (pegaspargase)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: NK-T-Cell Lymphoma, Extranodal | Phase 2 | Status: UNKNOWN